Amylyx Pharmaceuticals Inc's total assets for Q4 2023 were $517.45M, an increase of 10.90% from the previous quarter. AMLX total liabilities were $84.02M for the fiscal quarter, a 74.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.